Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 264K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Rathmell, J. C. Articles by Goodnow, C. C. Search for Related Content PubMed PubMed Citation Articles by Rathmell, J. C. Articles by Goodnow, C. C. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                            What's this?

Articles

Jeffrey C. Rathmell^*, Sylvie Fournier, Bennett C. Weintraub^*,, James P. Allison, and Christopher C. Goodnow^*,

From the ^* Howard Hughes Medical Institute and the Department of Microbiology and Immunology, Stanford University, Stanford, California 94305; the Australian Cancer Research Foundation Genetics Laboratory and Medical Genome Centre, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia; and the Department of Molecular and Cellular Biology and the Cancer Research Laboratory, University of California at Berkeley, Berkeley, California 94720

Peripheral tolerance mechanisms normally prevent delivery of T cell help to anergic self-reactive B cells that accumulate in the T zones of spleen and lymph nodes. Chronic exposure to self-antigens desensitizes B cell antigen receptor (BCR) signaling on anergic B cells so that they are not stimulated into clonal expansion by CD4⁺ T cells but instead are eliminated by Fas (CD95)-induced apoptosis. Because a range of BCR-induced signals and responses are repressed in anergic B cells, it is not known which of these are critical to regulate for Fas-mediated peripheral tolerance. Display of the costimulatory molecule, B7.2 (CD86), represents a potentially important early response to acute BCR engagement that is poorly induced by antigen on anergic B cells. We show here that restoring B7.2 expression on tolerant B cells using a constitutively expressed B7.2 transgene is sufficient to prevent Fas-mediated deletion and to trigger extensive T cell–dependent clonal expansion and autoantibody secretion in the presence of specific T cells. Dysregulated expression of B7.2 on tolerant B cells caused a more extreme reversal of peripheral tolerance than that caused by defects in Fas or Fas ligand, and resulted in T cell–dependent clonal expansion and antibody secretion comparable in magnitude to that made by foreign antigen-specific B cells. These findings demonstrate that repression of B7.2 is critical to eliminate autoreactive B cells by Fas in B cell–T cell interactions. The possible role of B7.2 dysregulation in systemic autoimmune diseases is discussed.

Key Words: B7.2 (CD86) • Fas (CD95) • B cell antigen receptor • B cell • autoimmunity

J.C. Rathmell's current address is Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, 924 E. 57th St., R402, Chicago, IL 60637.

Abbreviations used: BCR, B cell antigen receptor; CTLA4, cytotoxic lymphocyte–associated antigen 4; HEL, hen egg lysozyme; HPRT, hypoxanthine phosphoribosyltransferase; L, ligand; PI, propidium iodide; RT, reverse transcription; tg, transgenic.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS